Biotech Surges as Programmable Cell Therapies Transform Chronic Disease Care
Issued on behalf of Avant Technologies Inc. VANCOUVER – USA News Group News Commentary – The autologous cell therapy market surpassed $10.1 billion in 2025 as biotechnology companies race to commercialize therapies that read,...
Read More